Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 40.65
+0.15 (0.37%)
Jan 22, 2026, 11:40 AM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.74 billion as of January 21, 2026. Its market cap has increased by 13.88% in one year.
Market Cap
1.74B
Enterprise Value
1.25B
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.65
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 1.74B, an increase of 17.64%. That is a compound annual growth rate of 3.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.84B | 34.22% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anti-Microbial Savior BioteQ | 2.44B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.41B |
| TaiRx | 2.38B |
| TWi Biotechnology | 2.21B |
| Chunghwa Chemical Synthesis & Biotech | 2.00B |
| Genomics BioSci & Tech. | 1.81B |
| NeoCore Technology | 1.58B |
| Advagene Biopharma | 1.56B |